Price close 16 Nov 2026
- 1M
- −0.7%
- 6M
- +3.6%
- YTD
- +8.9%
- 1Y
- +8.7%
- 3Y
- +45.4%
Price change over each period, from daily closes; dividends not included.
Price change over each period, from daily closes; dividends not included.
JPMorgan International Research Enhanced Equity ETF (JIRE) is a developed markets international equity exchange-traded fund from J.P. Morgan.
It charges 0.29% a year — $29.00 on $10,000, and holds 213 positions, the ten largest 16.9% of the fund.
Its net assets were $11.2 billion on July 31, 2026; it is the 15th largest of the 16 developed markets funds among the 300 largest ETFs.
From the fund's prospectus and its latest holdings (31 Jul 2026), compiled and checked by AapWire.
| Holding | Weight | Weight bar |
|---|---|---|
| ASML Holding NV ASML | 3.48% | |
| Siemens AG | 1.78% | |
| AstraZeneca plc AZN | 1.69% | |
| Shell plc SHEL | 1.55% | |
| HSBC Holdings plc HSBC | 1.54% | |
| Allianz SE | 1.51% | |
| Banco Santander SA | 1.36% | |
| UniCredit SpA | 1.33% | |
| Nestle SA | 1.33% | |
| Roche Holding AG | 1.32% |
| Financials | 26.8% |
|---|---|
| Industrials | 17.5% |
| Information Technology | 14.1% |
| Health Care | 11.1% |
| Consumer Staples | 7.2% |
| Consumer Discretionary | 6.4% |
| Utilities | 4.6% |
| Materials | 4.3% |
| Energy | 4.1% |
| Communication Services | 2.8% |
| Real Estate | 1.1% |
The eleven sectors of the company pages: an S&P 500 member counts in its index sector, any other holding in its industry's; shares of the stock that has a sector.
Countries as the fund reports them: JP 23.4%, GB 16.6%, FR 11.4%, DE 10.9%, CH 7.4%, NL 6.9%.
| Category | Developed markets · International equity |
|---|---|
| Issuer | J.P. Morgan |
| Index | None stated |
| Expense ratio | 0.29% · $29.00 a year on $10,000 |
| Net assets | $11.2B · 31 Jul 2026 |
| Holdings | 213 · ten largest 16.9% |
| Legal form | Registered fund |
| Rank in category | 15 of 16 · by size, among the 300 largest ETFs |
| Year | Total return |
|---|---|
| 2025 | 32.1% |
| 2024 | 3.0% |
| 2023 | 19.7% |
| 2022 | -13.7% |
| 2021 | 12.9% |
| 2020 | 5.4% |
| 2019 | 22.0% |
| 2018 | -14.7% |
| 2017 | 23.3% |
| 2016 | 2.1% |
From the prospectus filed 25 Feb 2026.
JIRE's expense ratio is 0.29% a year, $29.00 on a $10,000 holding, from its latest prospectus.
JIRE held 213 positions on July 31, 2026.
ASML Holding NV (3.5%), Siemens AG (1.8%), AstraZeneca plc (1.7%), Shell plc (1.5%), HSBC Holdings plc (1.5%).
JIRE is issued by J.P. Morgan; it is a registered fund.
In the terminal
The fund's costs and returns are read from its prospectus, its positions from its latest report or its issuer's own file, and its category from what it holds and how it names itself. A figure that cannot be read is left blank. See data and methodology.